Nicotine formulation

Abstract

A method of manufacturing a nicotine-containing mucoadhesive film, by preparing an aqueous solution at a pH of from 9.5 to 13, said solution comprising (i) a nicotine salt, (ii) an alkaline pH-regulating agent, and (iii) a film-forming agent comprising an alginate salt of monovalent cation or a mixture of alginate salts of monovalent cations, the film-forming agent having a mean guluronate (G) content of from 50 to 85% by weight, a mean mannuronate (M) content of from 15 to 50% by weight, a mean molecular weight of from 30,000 g/mol to 90,000 g/mol and being such that a 10% aqueous solution thereof at a temperature of 20° C. has a viscosity of 100-1000 mPas, as measured at a shear rate of 20 rpm by use of a Brookfield viscometer with a spindle No. 2; distributing the solution onto a solid surface; and permitting the solution to dry on said surface. A nicotine-containing mucoadhesive film.

1 . A mucoadhesive nicotine-containing film, obtainable by
 preparing an aqueous solution at a pH of from 9.5 to 13, by admixing: (i) a nicotine salt, (ii) an alkaline pH regulating agent, and (iii) a film-forming agent comprising an alginate salt of monovalent cation or a mixture of alginate salts of monovalent cations, the film-forming agent having a mean guluronate content of from 50 to 85% by weight, a mean mannuronate content of from 15 to 50% by weight, a mean molecular weight of from 30,000 g/mol to 90,000 g/mol and being such that a 10% aqueous solution thereof at a temperature of 20° C. has a viscosity of 100-1000 mPas, as measured at a shear rate of 20 rpm by use of a Brookfield viscometer with a spindle No. 2;   distributing the solution onto a solid surface; and   permitting the solution to dry on said surface.   
     
     
         2 . The film according to  claim 1 , wherein the pH regulating agent is LiOH, NaOH or KOH. 
     
     
         3 . The film according to  claim 1 , wherein the nicotine salt is an acid addition salt. 
     
     
         4 . The film according to  claim 3 , wherein the acid addition salt is a salt of tartaric acid. 
     
     
         5 . The film according to  claim 2 , wherein the nicotine salt is an acid addition salt. 
     
     
         6 . The film according to  claim 5 , wherein the acid addition salt is a salt of tartaric acid. 
     
     
         7 . The film according to  claim 1 , comprising a plasticizer. 
     
     
         8 . The film according to  claim 1 , comprising a filler. 
     
     
         9 . The film according to  claim 1 , having a thickness in the range of from 0.01 mm to 2 mm. 
     
     
         10 . The film according to  claim 1 , having a loss of nicotine of less than 5% by weight after 100 days in air at a temperature ranging from 21 to 24° C. and a relative humidity of 19-32%. 
     
     
         11 . A nicotine dosage unit comprising a film according to  claim 1 . 
     
     
         12 . The dosage unit according to  claim 11 , having a surface area in the range of from 2 to 8 cm 2 . 
     
     
         13 . The dosage unit according to  claim 11 , having a nicotine content in the range of from 0.5 mg to 4 mg. 
     
     
         14 . The dosage unit according to  claim 12 , having a nicotine content in the range of from 0.5 mg to 4 mg. 
     
     
         15 . A method of manufacturing a nicotine-containing mucoadhesive film, comprising:
 preparing an aqueous solution at a pH of from 9.5 to 13, by admixing: (i) a nicotine salt, (ii) an alkaline pH regulating agent, and (iii) a film-forming agent comprising an alginate salt of monovalent cation or a mixture of alginate salts of monovalent cations, the film-forming agent having a mean guluronate content of from 50 to 85% by weight, a mean mannuronate content of from 15 to 50% by weight, a mean molecular weight of from 30,000 g/mol to 90,000 g/mol and being such that a 10% aqueous solution thereof at a temperature of 20° C. has a viscosity of 100-1000 mPas, as measured at a shear rate of 20 rpm by use of a Brookfield viscometer with a spindle No. 2;   distributing the solution onto a solid surface; and   permitting the solution to dry on said surface.   
     
     
         16 . The method according to  claim 15 , comprising adding a plasticizer to the solution. 
     
     
         17 . The method according to  claim 15 , comprising adding a filler to the solution. 
     
     
         18 . The method according to  claim 15 , comprising dividing the film into dosage units. 
     
     
         19 . A nicotine-containing film formulation for buccal administration of free base nicotine, wherein the film formulation has a decrease in nicotine content of less than 5% by weight after 100 days in air at a temperature ranging from 21 to 24° C. and a relative humidity of 19-32%. 
     
     
         20 . A method of preparing a nicotine-containing film formulation for buccal administration of free base nicotine, wherein the film formulation has a decrease in nicotine content of less than 5% by weight after 100 days in air at a temperature ranging from 21 to 24° C. and a relative humidity of 19-32%, said method comprising
 preparing an aqueous solution at a pH of from 9.5 to 13, by admixing: (i) a nicotine salt, (ii) an alkaline pH regulating agent, and (iii) a film-forming agent comprising an alginate salt of monovalent cation or a mixture of alginate salts of monovalent cations, the film-forming agent having a mean guluronate content of from 50 to 85% by weight, a mean mannuronate content of from 15 to 50% by weight, a mean molecular weight of from 30,000 g/mol to 90,000 g/mol and being such that a 10% aqueous solution thereof at a temperature of 20° C. has a viscosity of 100-1000 mPas, as measured at a shear rate of 20 rpm by use of a Brookfield viscometer with a spindle No. 2; 
 distributing the solution onto a solid surface; and 
 permitting the solution to dry on said surface.